We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nose Swabs May Distinguish Babies with RSV Needing Longer Intensive Care

By LabMedica International staff writers
Posted on 04 Nov 2022
Print article
Image: A new study has linked more severe RSV with greater damage to cells lining the nose (Photo courtesy of Pexels)
Image: A new study has linked more severe RSV with greater damage to cells lining the nose (Photo courtesy of Pexels)

When a child with respiratory syncytial virus (RSV) requires intensive care, parents often ask about how long it will take before their child can go home. Currently, there is no reliable way to answer this question. Now, the results of a new study could pave the way for the development of a PCR test to distinguish the children who would likely take longer to recover from critical RSV illness

Researchers from Ann & Robert H. Lurie Children’s Hospital of Chicago (Chicago, IL, USA) used nose swabs from children with RSV in the pediatric intensive care unit (PICU) within a few days of hospital stay to examine what genes turn on in response to the virus. They found that despite the same quantity of RSV and the same clinical presentation, some children had signs of greater damage to the cells lining the nose, and this correlated to longer PICU stays. These findings would need to be validated in a larger group of children before they could be used clinically. If the results hold true in larger studies, then a PCR test could be developed to distinguish the children who would likely take longer to recover from critical RSV illness.

“We were excited to find that the severity of a child’s illness related to the different sets of genes turned on in their body’s response to RSV,” said senior author Bria Coates, MD, Critical Care physician at Lurie Children’s and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine. “The ability to identify which infants with RSV in intensive care will recover quickly and which patients will require a longer stay would provide invaluable information to parents and medical providers.”

“At this stage, we saw that more injury in the nasal mucosal membranes of children with RSV may be a marker of a dysregulated response to the virus and predict more prolonged illness,” said Dr. Coates, who also is the Crown Family Research Scholar in Developmental Biology. “These are promising findings that ultimately might offer better answers to parents and the care team.”

Related Links:
Ann & Robert H. Lurie Children’s Hospital of Chicago 

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
New
Ureaplasma Urealyticum Test
Duplicα RealTime Ureaplasma Urealyticum Kit

Print article

Channels

Immunology

view channel
Image: New insights into preterm infant immunity could inform care (Photo courtesy of 123RF)

New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood

Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.